ClinVar Miner

Submissions for variant NM_001113378.2(FANCI):c.824T>C (p.Ile275Thr)

gnomAD frequency: 0.00071  dbSNP: rs142906652
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000523947 SCV000616715 uncertain significance not provided 2017-07-07 criteria provided, single submitter clinical testing The I275T variant in the FANCI gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The I275T variant is observed in 64/66740 (0.095%) alleles from individuals of non-Finnish European background, in the ExAC dataset and no individuals were reported to be homozygous (Lek et al., 2016). The I275T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret I275T as a variant of uncertain significance.
Invitae RCV000529696 SCV000626322 uncertain significance Fanconi anemia 2022-10-18 criteria provided, single submitter clinical testing This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 275 of the FANCI protein (p.Ile275Thr). This variant is present in population databases (rs142906652, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with head and neck squamous cell carcinoma or breast cancer (PMID: 28678401, 30303537). ClinVar contains an entry for this variant (Variation ID: 449021). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt FANCI protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Illumina Laboratory Services, Illumina RCV001118938 SCV001277260 uncertain significance Fanconi anemia complementation group I 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
Baylor Genetics RCV001118938 SCV001525270 uncertain significance Fanconi anemia complementation group I 2019-06-12 criteria provided, single submitter clinical testing This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868].
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden RCV000523947 SCV002011135 uncertain significance not provided 2021-11-03 criteria provided, single submitter clinical testing
Genetic Services Laboratory, University of Chicago RCV001821453 SCV002066147 uncertain significance not specified 2020-03-23 criteria provided, single submitter clinical testing DNA sequence analysis of the FANCI gene demonstrated a sequence change, c.824T>C, in exon 10 that results in an amino acid change, p.Ile275Thr. This sequence change has been described in the gnomAD database with a frequency of 0.11% in the European sub-population (dbSNP rs142906652). The p.Ile275Thr change has been described in one individual with head and neck squamous cell carcinoma (PMID: 28678401). The p.Ile275Thr change affects a highly conserved amino acid residue located in a domain of the FANCI protein that is not known to be functional. In-silico predictions pathogenicity prediction tools (SIFT, PoluPhen2, Align GVGD, REVEL) provide contradictory results for the p.Ile275Thr substitution. Due to these contrasting evidences and the lack of functional studies, the clinical significance of the p.Ile275Thr change remains unknown at this time.
Sema4, Sema4 RCV000529696 SCV002532083 uncertain significance Fanconi anemia 2022-03-07 criteria provided, single submitter curation
Fulgent Genetics, Fulgent Genetics RCV001118938 SCV002775731 uncertain significance Fanconi anemia complementation group I 2022-04-06 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV001821453 SCV004241058 likely benign not specified 2023-12-13 criteria provided, single submitter clinical testing Variant summary: FANCI c.824T>C (p.Ile275Thr) results in a non-conservative amino acid change located in the FANCI solenoid 1 domain of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00055 in 251470 control chromosomes. The observed variant frequency is approximately 1.98 fold of the estimated maximal expected allele frequency for a pathogenic variant in FANCI causing Fanconi Anemia phenotype (0.00028), strongly suggesting that the variant is benign. c.824T>C has been reported in the literature in individuals affected with various cancer phenotypes including colorectal, head and neck and breast cancer (Poliani_2022, Chandrasekharappa_2018, Girard_2019). These reports do not provide unequivocal conclusions about association of the variant with Fanconi Anemia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 28678401, 30303537, 36356413). Eight submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely benign.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.